Lee Ji Hyun, Jung Ui Won, Kim Chang Sung, Choi Seong Ho, Cho Kyoo Sung
Department of Periodontology, Research Institute for Periodontal regeneration, College of Dentistry, Yonsei University, Seoul, South Korea.
Clin Oral Implants Res. 2008 Aug;19(8):767-71. doi: 10.1111/j.1600-0501.2008.01520.x.
This study evaluated both the clinical and histological aspects of bone formation in maxillary sinus augmentation using MBCP as the bone-grafting material.
MBCP was used as a primary bone substitute for maxillary sinus augmentation. Fifty-two patients were selected after a medical and dental examination, and were divided into the following three groups: those augmented with MBCP only; MBCP combined with irradiated cancellous bone; and MBCP combined with intraoral autogenous bone. After a healing period (average 6.78 months after surgery), bone cores were harvested for a histological evaluation and the implant fixtures were installed. These bone cores were evaluated via light microscope and implants were followed up for at least six months after loading.
Four to ten months after surgery, new vital bone surrounding the MBCP particles was observed in 18 bone biopsies. Two out of the 130 implants installed were explanted due to a failure of osseointegration before the prosthetic procedure. All the remaining implants were functioning for 6 to 27 months (average 12.96 months). The cumulative survival rate of the implants was 98.46%.
These results show that MBCP can be used as a grafting material for sinus floor augmentation, whether combined with other bone graft materials or not, and lead to a predictable prognosis for dental implants in the posterior maxillary area where there is insufficient vertical height for fixture installation.
本研究评估了使用MBCP作为骨移植材料进行上颌窦提升术中骨形成的临床和组织学方面。
MBCP用作上颌窦提升的主要骨替代物。52例患者经医学和牙科检查后入选,分为以下三组:仅用MBCP进行提升;MBCP联合照射后的松质骨;MBCP联合口内自体骨。在愈合期(术后平均6.78个月)后,采集骨芯进行组织学评估,并安装种植体基台。通过光学显微镜对这些骨芯进行评估,并在加载后对种植体进行至少6个月的随访。
术后4至10个月,在18例骨活检中观察到MBCP颗粒周围有新的活性骨。在安装的130颗种植体中,有2颗在修复手术前因骨结合失败而被取出。其余所有种植体均正常使用6至27个月(平均12.96个月)。种植体的累积生存率为98.46%。
这些结果表明,无论是否与其他骨移植材料联合使用,MBCP都可作为窦底提升的移植材料,并为上颌后部区域种植体垂直高度不足的牙种植提供可预测的预后。